In recent weeks, biotech companies have faced setbacks in moving forward with clinical trials due to operational delays at the FDA, according to an exclusive report from The Wall Street Journal ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Animal testing requirements for monoclonal antibodies and other medications will be “reduced, refined or potentially replaced ...

“This is a really exciting new area that has tremendous potential to assist drug discovery and development,” says Koguchi. “It’s creating new avenues of research that were never before ...

In a landmark decision poised to revolutionize drug development, the U.S. Food and Drug Administration (FDA) has announced a ...

Traditionally, hybridoma technology — a five-step process based on the fusion ... including antibody drug development. The single cells flow one by one in the droplets, while the testing and ...